Facilitating Earlier Diagnosis of Alzheimer’s Disease

Tuesday, July 29, 2025

6:15 AM – 7:45 AM ET simulcast
5:15 AM – 6:45 AM CT
4:15 AM – 5:45 AM MT
3:15 AM – 4:45 AM PT

Program Features

  • Holographic Caregiver Avatar
  • DETECT Alzheimer’s website
  • Online personalized quality-improvement poster-generation portal
  • DETECT Alzheimer’s Ambassador program

Program Overview

Designed as an interactive case-based learning program, attendees will be guided through the latest developments in the diagnosis of mild cognitive impairment (MCI) due to Alzheimer’s disease (AD). Expert faculty will discuss the use of validated cognitive assessments to screen for early symptomatic AD. They will also present updated diagnostic guidelines in AD, leveraging blood-based, CSF-based, and imaging biomarkers. Attendees will also learn about the importance of including the patient and their family caregiver in the assessment and diagnosis of MCI and/or Alzheimer’s disease.

Target Audience

This program will meet the educational needs of healthcare providers involved in the diagnosis and continued care of patients with early symptomatic AD on a global level, including specialists (i.e., dementia specialists, neurologists, geriatricians, geriatric psychiatrists), nurse practitioners (NPs; working in AD specialty settings), and physicians assistants (PAs; working in AD specialty settings).

Learning Objectives

  • Evaluate opportunities for the use of validated cognitive assessments to screen for early symptomatic AD within a multidisciplinary care paradigm
  • Appraise updated diagnostic guidelines in AD leveraging blood-based, CSF-based, and imaging biomarkers

THE ACCREDITATION POLICY IS APPLICABLE TO EACH EVENT

Joint Accreditation Statement

Joint Accreditation Statement

In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Credit Designation Statement

Med Learning Group designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

Nurses (ANCC) Credit Designation

Med Learning Group designates this activity for a maximum of up to 1.5 ANCC contact hours.

AAPA Credit Designation Statement – Live

AAPA Credit Designation Statement

Med Learning Group has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

EACCME Credit Designation Statement

The American Medical Association has an agreement of mutual recognition of Continuing Medical Education (CME) credits with the European Union of Medical Specialists (UEMS), the accreditation body for European countries. Physicians interested in converting AMA PRA Category 1 Credits™ to UEMS-European Accreditation Council for Continuing Medical Education CME credits (ECMECs) should contact the UEMS at mutualrecognition@uems.eu

Disclosure Policy Statement

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

Disclosure Of Unlabeled Use

Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

Disclaimer

Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.

For CE questions, please contact Med Learning Group at info@medlearninggroup.com

Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/

Americans With Disabilities Act

Event Staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

Release date: July 29, 2025
Expiration date: July 29, 2025
Estimated time to completion: 1.5 hours